Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Cocrystal Pharma, Inc. (COCP) had Income from Continuous Operations of $-3.96M for the most recently reported fiscal quarter, ending 2024-03-31.
| Income Statement Financials | |
-- |
|
$-3.96M |
|
-- |
|
-- |
|
$4.16M |
|
$-4.16M |
|
$0.20M |
|
$-3.96M |
|
$-3.96M |
|
$-3.96M |
|
|
Income from Continuous Operations |
$-3.96M |
$-3.96M |
|
$-3.96M |
|
$-4.16M |
|
$-4.04M |
|
10.17M |
|
10.17M |
|
$-0.39 |
|
$-0.39 |
|
| Balance Sheet Financials | |
$24.49M |
|
$0.24M |
|
$2.05M |
|
$26.55M |
|
$2.38M |
|
-- |
|
$1.58M |
|
$3.96M |
|
$22.59M |
|
$22.59M |
|
$22.59M |
|
10.17M |
|
| Cash Flow Statement Financials | |
$-4.50M |
|
$-0.01M |
|
-- |
|
$26.43M |
|
$21.92M |
|
$-4.51M |
|
$0.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.30 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.51M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-17.52% |
|
-17.52% |
|
-14.90% |
|
-17.52% |
|
$2.22 |
|
$-0.44 |
|
$-0.44 |
|